In less than three months, hearing giant WS Audiology can celebrate the three-year anniversary of the day then-companies Widex and Sivantos merged into one, under the name WSA.
Though the Covid-19 pandemic has been a fact of life for most of its lifetime, WSA is now at a place where it can announce that the integration of the two companies is largely complete, according to the company's CEO Eric Bernard.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.